Mirum Pharmaceuticals (MIRM) Current Assets (2018 - 2026)

Mirum Pharmaceuticals' Current Assets history runs 9 years deep, the most recent figure standing at $569.4 million for Q1 2026.

• On a quarterly basis, Current Assets rose 38.61% year-over-year to $569.4 million in Q1 2026; TTM through Mar 2026 was $569.4 million, a 38.61% increase from a year earlier, with the FY2025 full-year figure at $549.7 million, up 39.94% from the prior year.
• Current Assets grew to $569.4 million in Q1 2026 per MIRM's latest filing, from $549.7 million in the prior quarter.
• Across five years, Current Assets topped out at $569.4 million in Q1 2026 and bottomed at $147.2 million in Q2 2022.
• The 5-year median for Current Assets is $387.5 million (2023), against an average of $358.3 million.
• Across the five-year window, Current Assets plunged 35.52% in 2022 and surged 160.46% in 2023, its largest moves.
• Year by year, Current Assets stood at $190.2 million in 2022, then surged by 103.73% to $387.5 million in 2023, then rose by 1.35% to $392.8 million in 2024, then jumped by 39.94% to $549.7 million in 2025, then rose by 3.59% to $569.4 million in 2026.
• Per Business Quant, the three latest MIRM Current Assets figures stand at $569.4 million (Q1 2026), $549.7 million (Q4 2025), and $530.6 million (Q3 2025).